Paul Darveniza

1.2k citations
24 papers · 756 indexed · h-index 13

Paul Darveniza

22 papers receiving 725 citations

Peers

Paul Darveniza
Comparison fields: 5 of 82
  • Clinical Biochemistry 175
  • Neurology 138
  • Parasitology 56
  • Speech and Hearing 58
  • Physiology 165
Replace Anna Maria Laverda with:
Anna Maria Laverda Italy
Richard G. Curless United States
Cengiz Yakıncı Türkiye
A B Taly India
Robert Birnbacher Austria
Darab K. Dastur India
Arturo Carta Italy
Jan‐Edvin Olsson Sweden
N. H. Wadia India
Rodrigo Secolin Brazil
Paul Darveniza relative to Anna Maria Laverda Italy Anna Maria Laverda's profile →
Citations per field
00.5×8.3×
Anna Maria Laverda · 1×
Citations per year

Countries citing papers authored by Paul Darveniza

Since Specialization
Citations

This map shows the geographic impact of Paul Darveniza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Darveniza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Darveniza more than expected).

Fields of papers citing papers by Paul Darveniza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Darveniza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Darveniza. The network helps show where Paul Darveniza may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul Darveniza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Darveniza Line = papers co-authored together Paul Darveniza links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20224
3 20175
4 20174
5 201611
6 20147
7 20080
8 200340
9 199661
10 199541
11 199114
12 198928
13 19883
14
Spinal cord and cerebellar-like syndromes associated with the use of cyclosporine in human recipients of allogeneic marrow transplants.
198525
15 198430
16 198499
17 19799
18 197970
19 19779
20 1977147

About Paul Darveniza

Paul Darveniza is a scholar working on Speech and Hearing, Neurology and Clinical Biochemistry, having authored 24 papers that have together received 756 indexed citations. Recurring topics across this work include Dysphagia Assessment and Management (6 papers), Voice and Speech Disorders (6 papers), Botulinum Toxin and Related Neurological Disorders (4 papers), Neurological Complications and Syndromes (3 papers), Mitochondrial Function and Pathology (2 papers), Metabolism and Genetic Disorders (2 papers), Neurological disorders and treatments (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Clinical Biochemistry (175 citations), Neurology (138 citations) and Parasitology (56 citations). Paul Darveniza has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include J A Morgan-Hughes, D. N. Landon, John M. Land, J. B. Clark, A Concannon, J. C. Biggs, J Boland, Sidney N. Kahn, Anthony J. Dodds and Rosemary A. Eames. Their work appears in journals such as Brain, Biochemical Journal and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026